Staughton Laurocapram Emulsio

We acknowledge the assistance provided by K. Carlson and B. Selvamani for figures. REFERENCES

1. Lemberger AP. Eczema and psoriasis remedies. In: Griffernhagen GB, Hawking LL, eds. Handbook of Non-Prescription Drugs. Washington, DC: American Pharmaceutical Association, 1973:161-166.

2. Wilkes GL, Brown IA, Wildnauer RH. The biomechanical properties of skin. CRC Crit Rev Bioeng 1973; l(4):453^t95.

3. Scheuplein RJ, Blank IH. Permeability of the skin. Physiol Rev 1971; 51(4):702-747.

4. Montagna W. Parakkal PF. The Structure and Function of Skin. 3rd ed. New York: Academic Press, 1974.

5. Elias PM, Grayson S, Lampe MA, et al. The intercorneocyte space. In: Marks R, Plewig G, eds. Stratum Corneum. New York: Springer-Verlag, 1983:53-67.

6. Tingstad JE, Wurster DE, Higuchi T. Investigation of human skin lipids n. J Am Pharm Assoc 1958; 47(3 pt 1): 192-193.

7. Scheuplein RJ. Mechanism of percutaneous adsorption. I. Routes of penetration and the influence of solubility. J Invest Dermatol 1965; 45(5):334-346.

8. Baker H, Kligman AM. Measurement of transepidermal water loss by electrical hygrometry. Instrumentation and responses to physical and chemical insults. Arch Dermatol 1967; 96(4): 441-452.

9. Scheuplein RJ. Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Dermatol 1967; 48(l):79-88.

10. Woodburne RT. Essentials of Human Anatomy. New York: Oxford University Press, 1967:6.

11. Rothman S. Percutaneous absorption. In: Rothman S, ed. Physiology and Biochemistry of the Skin. Chicago: University of Chicago Press, 1954:26-59.

12. McKenzie AW. Percutaneous absorption of steroids. Arch Dermatol 1963; 86:611-614.

13. Stoughton RB. Percutaneous absorption. South Med J 1962; 55:1134-1138.

14. Szabo G. The number of eccrine sweat glands in human skin. Adv Biol Skin 1962; 3:1-5.

15. Katz M, Poulsen BJ. Absorption of drugs through the skin. In: Brodie BB, Gillette J, eds. Handbook of Experimental Pharmacology, New Series. Vol 28. New York: Springer-Verlag, 1972:103.

16. Peck SM, Russ WR. Propionate-caprylate mixtures in the treatment of dermatomycoses. Arch Dermatol Syph 1947; 56:601-608.

17. Liggins MR. Help for your sunburn prone patientsPatient Care 1974:56.

18. Rushmer RF, Buettner KJ, Short JM, et al. The skin. Science 1966; 154(747):343-348.

19. Idson B. Water and the skin. J Soc Cosmet Chem 1973; 24(3): 197-212.

20. Laden K. Natural moisturizing factors in skin. Am Perfum Cosmet 1967; 82(10):77-79.

21. Robinson JR. O-T-C deodorants and antiperspirants. J Am Pharm Assoc 1967; 7(2):75-77, 93.

22. Stoughton RB. Status of topical therapy. Clin Pharmacol Ther 1974; 16(5 pt 2):869-872.

23. Voorhees JJ, Duell EA, Stawiski M, et al. Molecular and clinical pharmacology of psoriasis. Clin Pharmacol Ther 1974; 16(5 pt 2):919-921.

24. Good WR. Transdermal drug-delivery systems. Med Device Diagn Ind 1986:34-42.

25. Cleary GW. Transdermal controlled release systems. In: Langer RS, Wise DL, eds. Medical Applications of Controlled Release. Vol 1. Boca Raton, FL: CRC Press, 1983:203-251.

26. Chien YW. Transdermal drug delivery and delivery systems. In: Chien YW, ed. Novel Drug Delivery Systems. New York: Marcel Dekker, 1982:149-217.

27. Marty JP, Guy RH, Maibach HI. Percutaneous penetration as a method of delivery to muscle and other tissues. In: Bronaugh RL, Maibach HI, eds. Percutaneous Absorption. 2nd ed. New York: Marcel Dekker, 1989:511-529.

28. Behl CR, Bellantone NH, Flynn GL. Influence of age on percutaneous absorption of drug substances. In: Bronaugh RL, Maibach HI, eds. Percutaneous Absorption. New York: Marcel Dekker, 1985:183-212.

29. Fisher LB. In vitro studies on the permeability of human skin. In: Bronaugh RL, Maibach HI, eds. Percutaneous Absorption. New York: Marcel Dekker, 1985:213-222.

30. Weingand DA, Haygood C, Gaylor JR, et al. Racial variations in the cutaneous barrier. In: Drill VA, Lazar P, eds. Current Concepts in Cutaneous Toxicity. New York: Academic Press, 1980:221-235.

31. Weigand DA, Haygood C, Gaylor JR. Cell layers and density of Negro and Caucasian stratum corneum. J Invest Dermatol 1974; 62(6):563-568.

32. Durrheim H, Flynn GL, Higuchi WI, et al. Permeation of hairless mouse skin I: experimental methods and comparison with human epidermal permeation by alkanols. J Pharm Sci 1980; 69:781-786.

33. Flynn GL, Linn EE, Kurihara-Bergstrom T, et al. Parameters of skin condition and function. In: Kydonieus AF, Berner B, eds. Transdermal Delivery of Drugs. Vol 2. Boca Raton, FL: CRC Press, 1987:3-17.

34. Mathias CGT. Clinical and experimental aspects of cutaneous irritation. In: Marzulli FN, Maibach HI, eds. Dermatotoxicology. 3rd ed. New York: Hemisphere Publishing, 1987:173-189.

35. Roberts MS, Anderson RA, Swarbrick J, et al. The percutaneous absorption of phenolic compounds: the mechanism of diffusion across the stratum corneum. J Pharm Pharmacol 1978; 30(8):486-490.

36. Baden HP, Goldsmith LA, Bonar L. Conformational changes in the fibrous protein of epidermis. J Invest Dermatol 1973; 60(4):215-218.

37. Keipert JA. The absorption of topical corticosteroids, with particular reference to percutaneous absorption in infancy and childhood. Med J Aust 1971; 1(19): 1021-1025.

38. Flynn GL. Mechanisms of percutaneous absorption from physicochemical evidence. In: Bronaugh RL, Maibach HI, eds. Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery. 2nd ed. New York: Marcel Dekker, 1989:27-51.

39. Flynn GL, Yalkowsky SH, Roseman TJ. Mass transport phenomena and models: theoretical concepts. J Pharm Sci 1974; 63(4):479-510.

40. Scheuplein RJ, Bronaugh RL. Percutaneous absorption. In: Goldsmilh LA, ed. Biochemistry and Physiology of the Skin. Vol 2. New York: Oxford University Press, 1983:1255-1295.

41. Toll R, Jacobi U, Richter H, et al. Penetration profile of microspheres in follicular targeting of terminal follicles. J Invest Dermatol 2004; 123(1): 168-176.

42. Valiveti S, Lu GW. Diffusion properties of model compounds in artificial sebum. Int J Pharm 2007; 345(l/2):88-94.

43. Valiveti S, Wesley J, Lu GW. Investigation of drug partition property in artificial sebum. Int J Pharm 2008; 346(1/2): 10-16.

44. Higuchi T, Davis SS. Thermodynamic analysis of structure-activity relationships of drugs. Prediction of optimal structure. J Pharm Sci 1970; 59(10): 1376-1383.

45. Davis SS, Higuchi T, Rytting JH. Determination of thermodynamics of functional groups in solutions of drug molecules. Adv Pharm Sci 1974; 4:73-261.

46. Pozzo DA, Pastori N. Percutaneous absorption of parabens from cosmetic formulations. Int J Cosmet Sci 1996; 18:57-66.

47. Scheuplein RJ, Blank IH, Brauner GJ, et al. Percutaneous absorption of steroids. J Invest Dermatol 1969; 52(l):63-70.

48. Flynn GL. Physicochemical determinants of skin absorption. In: Gerrity TR Henry CJ, eds. Principles of Route-to-Route Extrapolation for Risk Assessment. New York: Elsevier, 1990:93-128.

49. Potts RO, Guy RH. Predicting skin permeability. Pharm Res 1992; 9(5):663-669.

50. Erdi NZ, Cruz MM, Battista OA. Rheological characteristics of polymeric microcrystal-gels. J Colloid Interface Sci 1968; 28(l):36-47.

51. Thau P, Fox C. A new procedure for the preparation of polyethylene-mineral oil gels. J Soc Cosmet Chem 1965; 16(6):359-363.

52. Foster S, Wurster DE, Higuchi T, et al. A pharmaceutical study of Jelene ointment base. J Am Pharm Assoc 1951; 40(3): 123-125.

53. Barry BW. Control of oil-in-water emulsion consistency using mixed emulsifiers. J Pharm Pharmacol 1969; 21(8):533-540.

54. Arnott S, Fulmer A, Scott WE, et al. Agarose double helix and its function in agarose gel structure. J Mol Biol 1974; 90(2):269-284.

55. Physician's Desk Reference. 28th ed. Oradell, NJ: Medical Economics, 1974:1460.

56. Flynn GL, Roseman TJ. Membrane diffusion. II. Influence of physical adsorption on molecular flux through heterogeneous dimethylpolysiloxane barriers. J Pharm Sei 1971; 60(12): 1788-1796.

57. Flynn GL. Structural approach to partitioning: estimation of steroid partition coefficients based upon molecular constitution. J Pharm Sei 1971; 60(3):345-353.

58. Hagen TA. Physicochemical Study of Hydrocortisone and Hydrocortisone n-Alkyl-21 Esters (thesis). University of Michigan, 1979.

59. Smith WM. An Inquiry into the Mechanism of Percutaneous Absorption of Hydrocortisone and Its n-Alkyl Esters (thesis). University of Michigan, 1982.

60. Schlägel CA. Penetration and action of glucocorticoids. Adv Biol Skin 1972; 12:339-356.

61. Mckenzie AW, Atkinson RM. Topical activities of betamethasone esters in man. Arch Dermatol 1964; 89:741-746.

62. Saracen G, Elena Spaccamela M. Influence of the C-atom chain on the solubility of a homologous series in water. Ann Chim (Rome, Italy) 1958; 48:1357-1370.

63. Yalkowsky SH, Flynn GL, Slunick TG. Importance of chain length on physicochemical and crystalline properties of organic homologs. J Pharm Sei 1972; 61(6):852-857.

64. Flynn GL, Yalkowsky SH. Correlation and prediction of mass transport across membranes. I. Influence of alkyl chain length on flux-determining properties of barrier and diffusant. J Pharm Sei 1972; 61(6): 838-852.

65. Wurster DE. Some factors related to the formulation of preparations for percutaneous absorption. Am Perfum Cosmet 1965; 80(l):21-29.

66. Higuchi T. Physical chemical analysis of percutaneous absorption process from creams and ointments. J Soc Cosmet Chem 1960; 11:85-97.

67. Burdick KH, Poulsen B, Place VA. Extemporaneous formulation of corticosteroids for topical usage. JAMA 1970; 211(3):462^166.

68. Schaefer H, Redelmeier TE. Skin Barrier—Principles of Percutaneous Absorption. Basel, Switzerland: Karger, 1996:213-223.

69. McKenzie AW, Stoughton RB. Method for comparing percutaneous absorption of steroids. Arch Dermatol 1962; 86:608-610.

70. Vickers CFH. Stratum corneum reservoir for drugs. Adv Biol Skin 1972; 12:177-189.

71. Stoughton RB. Dimethylsulfoxide (DMSO) induction of a steroid reservoir in human skin. Arch Dermatol 1965; 91(6):657-660.

72. Scheuplein RJ, Ross L. Effects of surfactants and solvents on the permeability of epidermis. J Soc Cosmet Chem 1970; 21(13):853-873.

73. Elfbaum SG, Laden K. Effect of dimethyl sulfoxide on percutaneous absorption. Mechanistic study. II. J Soc Cosmet Chem 1968; 9(3): 163-172.

74. Goodman M, Barry BW. Action of penetration enhancers as assessed by differential scanning calorimetry. In: Bronaugh RL, Maibach HI, eds. Percutaneous Absorption. 2nd ed. New York: Marcel Dekker, 1989:567-593.

75. Abraham W, Downing DT. Factors affecting the formation, morphology and permeability of stratum corneum lipid bilayers in vitro. In: Scott RC, Guy RH, Hadgraft J, eds. Prediction of Percutaneous Penetration. London: IBC Technical Services, 1990:110-122.

76. Anderson BD, Higuchi WI, Raykar PV. Heterogeneity effects on permeability-partition coefficient relationships in human stratum corneum. Pharm Res 1988; 5(9):566-573.

77. Higuchi WI, Shannon WM, Fox JL, et al. Topical delivery of antiviral agents: in vivo/in vitro correlations. In: Anderson JM, Kim SW, eds. Recent Advances in Drug Delivery Systems. New York: Plenum Press, 1984:1-7.

78. Hou SYE, Flynn GL. Azone enhanced permeation of skin. Mediation of penetration of benzoic acid as a function of pH. Pharm Res 1986; 3(suppl):52S.

79. Flynn GL, Weiner ND. Topical and transdermal delivery—provinces of realism. In: Gurny R, ed. Dermal and Transdermal Drug Delivery. Stuttgart: APV, 1993:33-65.

80. Coldman MF, Poulsen BJ, Higuchi T. Enhancement of precutaneous absorption by the use of volatile-nonvolatile systems as vehicles. J Pharm Sei 1969; 58(9): 1098-1102.

81. Poulsen BJ, Young E, Coquilla V, et al. Effect of topical vehicle composition on the in vitro release of fluocinolone acetonide and its acetate ester. J Pharm Sei 1968; 57(6):928-933.

82. Shah VP, Ludden TM, Dighe SV, et al. Bioavailability and bioequivalence of transdermal drug delivery systems. Regulatory considerations. In: Shah VP, Maibach HI, eds. Topical Drug Bioavailability, Bioequivalence, and Penetration. New York: Plenum Press, 1993:415-424.

83. Kallings LO, Ringertz O, Silverstolpe L. Microbiological contamination of medical preparations. Acta Pharm Suec 1966; 3(3):219-228.

84. Fisher AA, Pascher F, Kanof NB. Allergic contact dermatitis due to ingredients of vehicles. A "vehicle tray" for patch testing. Arch Dermatol 1971; 104(3):286-290.

85. Mazer N, Fisher D, Fischer J, et al. Transfer of transdermal applied testosterone to clothing: a comparison of a testosterone patch versus a testosterone gel. J Sex Med 2005; 2(2):227-234.

86. Wester RC, Hui X, Maibach HI. In vivo human transfer of topical bioactive drug between individuals: estradiol. J Invest Dermatol 2006; 126(10):2190-2193.

Natural Treatments For Psoriasis

Natural Treatments For Psoriasis

Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.

Get My Free Ebook


Post a comment